Scientists at RMIT University have created new eye drops that can deliver medication directly to the retina, offering a painless alternative to injections for the treatment and prevention of severe eye diseases.
Researchers at Australia`s RMIT University have developed groundbreaking eye drops designed to deliver protective compounds directly to the retina. This marks a significant advancement, as until now, painful injections were often the only method for treating this crucial part of the eye, where conventional medications struggled to penetrate.
The developed formula is based on lutein, a potent antioxidant naturally found in gac fruit. In preclinical trials conducted on cell cultures and animal models, the specialized formulation successfully reached the posterior segments of the eye, providing effective protection against retinal damage. These drops hold immense potential for the prevention and treatment of age-related macular degeneration (AMD), a leading cause of vision loss in the elderly, as well as other severe retinal pathologies, including diabetic retinopathy.
Currently, patients suffering from such conditions are frequently subjected to regular intraocular injections. These procedures often entail fear, pain, and the inherent risk of complications. The new eye drop technology could revolutionize treatment by enabling at-home administration, thereby significantly enhancing patient comfort, alleviating the burden on healthcare professionals, and increasing the overall accessibility of vital therapy.
The scientists involved emphasize that while the project is still in its early stages of development, the successful results from in vitro and animal trials are very promising. Discussions are already underway with medical institutions to pave the way for human clinical trials in the near future.
It is also worth noting that previous research has indicated a significantly higher risk of developing age-related macular degeneration in individuals afflicted with psoriasis, compared to patients diagnosed with other skin conditions or depression. This highlights the broad impact retinal health can have across various systemic conditions.
